NDC product
Octagam Immune Globulin (Human)
NDC 68982-840 · Octapharma USA Inc
Key facts
| Product NDC | 68982-840 |
|---|---|
| Proprietary name | Octagam Immune Globulin (Human) |
| Nonproprietary name | Immune Globulin |
| Substances | HUMAN IMMUNOGLOBULIN G |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Labeler | Octapharma USA Inc |
| Product type | PLASMA DERIVATIVE |
| Marketing category | BLA |
| Application number | BLA125062 |
| Pharmacologic classes | Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE] |
| Marketing start | May 21, 2004 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: